TRPM3 and nonpapillary renal cell carcinoma: In human ccRCC cell lines (A498 and 786-O), TRPM3 silencing or treatment with mefenamic acid, a TRPM3 inhibitor, disrupted the formation and growth of tumors (Table 1).